MSP-2020

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameMSP-2020
Drug Alias NameMSP-2020
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor modulators
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsDepressive Disorder, MajorNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMindset Pharma IncMcQuade Center for Strategic Research and Development LLC
China Registration ClassN/A

Develop Information

Active CompaniesMcQuade Center for Strategic Research and Development LLCOtsuka Pharmaceutical Development & Commercialization IncMindset Pharma Inc
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A